Attention Deficit Drugs Part 2.docx
Document Details
Uploaded by leichnam
Emory & Henry College
Tags
Full Transcript
\#\#\# Slide 6 - Clonidine and Guanfacine (Alpha-2 Agonists): 1\. \*\*What is the primary mechanism of action of clonidine and guanfacine in treating ADHD?\*\* \- A) Inhibition of norepinephrine reuptake \- B) Stimulation of alpha-2 adrenergic receptors \- C) Inhibition of dopamine release \- D...
\#\#\# Slide 6 - Clonidine and Guanfacine (Alpha-2 Agonists): 1\. \*\*What is the primary mechanism of action of clonidine and guanfacine in treating ADHD?\*\* \- A) Inhibition of norepinephrine reuptake \- B) Stimulation of alpha-2 adrenergic receptors \- C) Inhibition of dopamine release \- D) Enhancement of serotonin release \*\*Answer\*\*: B) Stimulation of alpha-2 adrenergic receptors 2\. \*\*Which of the following is a common side effect of clonidine?\*\* \- A) Hypertension \- B) Hypotension \- C) Increased appetite \- D) Insomnia \*\*Answer\*\*: B) Hypotension 3\. \*\*What is a key difference between clonidine and guanfacine in their use for ADHD?\*\* \- A) Clonidine is longer-acting than guanfacine \- B) Guanfacine is less sedating than clonidine \- C) Clonidine is primarily used for treating anxiety \- D) Guanfacine is more commonly used for sleep disorders \*\*Answer\*\*: B) Guanfacine is less sedating than clonidine \#\#\# Slide 7 - Alpha-2 Agonists: Side Effects and Use: 4\. \*\*What is a common adverse effect seen with alpha-2 agonists in ADHD treatment?\*\* \- A) Increased energy \- B) Drowsiness \- C) Weight gain \- D) Seizures \*\*Answer\*\*: B) Drowsiness 5\. \*\*Which of the following is a potential complication of abruptly discontinuing clonidine?\*\* \- A) Hyperactivity \- B) Hypertensive crisis \- C) Bradycardia \- D) Weight loss \*\*Answer\*\*: B) Hypertensive crisis 6\. \*\*Which alpha-2 agonist is FDA-approved for both ADHD and hypertension?\*\* \- A) Clonidine \- B) Atomoxetine \- C) Guanfacine \- D) Methylphenidate \*\*Answer\*\*: A) Clonidine \#\#\# Slide 8 - Non-Stimulant Medications: 7\. \*\*Which non-stimulant medication is FDA-approved for ADHD?\*\* \- A) Atomoxetine \- B) Diazepam \- C) Methylphenidate \- D) Clonidine \*\*Answer\*\*: A) Atomoxetine 8\. \*\*What is an advantage of using atomoxetine over stimulants for ADHD treatment?\*\* \- A) Faster onset of action \- B) Lower risk of abuse \- C) Increased efficacy \- D) Reduced need for regular monitoring \*\*Answer\*\*: B) Lower risk of abuse 9\. \*\*How long does atomoxetine typically take to show its full therapeutic effects?\*\* \- A) 2-3 days \- B) 1 week \- C) 2 weeks \- D) 4-6 weeks \*\*Answer\*\*: D) 4-6 weeks \#\#\# Slide 9 - Atomoxetine Adverse Effects: 10\. \*\*What is a serious potential side effect of atomoxetine that requires monitoring?\*\* \- A) Hepatotoxicity \- B) Renal failure \- C) Cardiovascular collapse \- D) Nephrotoxicity \*\*Answer\*\*: A) Hepatotoxicity 11\. \*\*Which adverse effect is more common in children taking atomoxetine?\*\* \- A) Seizures \- B) Fatigue \- C) Weight gain \- D) GI upset \*\*Answer\*\*: D) GI upset 12\. \*\*What should be monitored regularly in patients on atomoxetine?\*\* \- A) Blood glucose levels \- B) Liver function tests \- C) Complete blood count \- D) Serum creatinine \*\*Answer\*\*: B) Liver function tests \#\#\# Slide 10 - Combination Therapy: 13\. \*\*When is combination therapy used in ADHD treatment?\*\* \- A) When a single drug is effective but causes weight gain \- B) When one drug does not adequately control symptoms \- C) To minimize drug dependence \- D) To avoid side effects of stimulants \*\*Answer\*\*: B) When one drug does not adequately control symptoms 14\. \*\*Which two classes of drugs are commonly combined in ADHD therapy?\*\* \- A) Stimulants and alpha-2 agonists \- B) Stimulants and benzodiazepines \- C) Stimulants and antidepressants \- D) Stimulants and antipsychotics \*\*Answer\*\*: A) Stimulants and alpha-2 agonists 15\. \*\*What is the main goal of using combination therapy for ADHD?\*\* \- A) To reduce the cost of medications \- B) To enhance efficacy and manage side effects \- C) To shorten treatment duration \- D) To eliminate the need for behavioral therapy \*\*Answer\*\*: B) To enhance efficacy and manage side effects Let me know if you\'d like more questions from the remaining slides 11 through 23!